23/03/2026
MZF4 Medical | Technical Advisory Board – 1st Session 2026
Last Wednesday, we held the 1st Technical Advisory Board (TAB) of MZF4 Medical, a key milestone in strengthening our commitment to clinically driven innovation and engineering excellence.
We had the privilege of hosting Dr. Wagner Castropil, an experienced orthopedic surgeon specialized in sports medicine (shoulder and knee). A graduate of the University of São Paulo, with residency at IOT-HC-FMUSP, he holds both a Master’s and a Doctorate in Medicine, with further specialization in sports medicine.
Throughout his career, he has played a key role in Brazilian sports medicine, serving as physician for institutions such as CBDU and CBJ, including participation in the Olympic Games (Athens 2004 and Beijing 2008). He is also the founder of Instituto Vita, one of Brazil’s leading orthopedic and sports medicine centers.
During this first session, Dr. Castropil guided the team through the three most relevant shoulder procedures:
• Rotator cuff repair
• Biceps Tenodesis
• Labrum repair
Through a detailed and practical approach, he demonstrated the use of different surgical tools and suture configurations, enabling our teams to connect engineering decisions directly with intraoperative reality.
Together with our full core team (spanning R&D, Innovation, Engineering, Sales and Operations) we explored the universe of suture anchors, from material evolution to biomechanical performance and surgical application.
As highlighted throughout the session, surgical repair is only as strong as its weakest interface. This principle continues to guide how we design:
• from anchor geometry and load distribution
• to suture behavior under cyclic stress
• to the interaction between implant, tissue and bone
At MZF4 Medical, our focus is clear: to drive both incremental and disruptive innovation delivering:
• greater system stability
• procedural simplification
• and ultimately, meaningful time efficiency in the operating room
Our approach remains consistent:
• Deep technical understanding
• Speed in development and ex*****on
• High level of customization
• Direct connection with the surgical field
• A constant pursuit of disruption through simplicity
As a natural next step, the TAB will be extending its activities into cadaver lab testing sessions, conducted in the presence of Dr. Castropil. This will allow us to further deepen our understanding of the real surgical application of the sutures and textile-based structures developed and assembled by MZF4 Medical, while also providing a controlled environment to evaluate new concept products not yet available on the market.
This is further reinforced by our dual commitment to excellence:
• ISO 13485:2016 (medical devices quality)
• ISO 56002 (innovation management)
Because innovation, for us, is not occasional, it is systematic. The TAB is not a one-time event. It is a structured platform to challenge assumptions, accelerate development, and co-create solutions with leading surgeons.
The next TAB session will take place in May, with a dedicated focus on innovations in arthroscopic knee procedures. We move forward... closer to the operating room, closer to reality, and closer to what truly matters.
MZF4 Medical: an MZF4® business unit.
